Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

White Paper

Product Alert – Niraparib API

Product Alert – Niraparib API

Niraparib binds to the PARP enzyme and prevents it from repairing single-strand breaks in DNA. This causes the cancer cell's DNA to become more damaged, leading to cell death. Since cancer cells often have more DNA damage than healthy cells, they are more sensitive to the effects of PARP inhibitors like Niraparib.

Dr. Reddy's API Offering

  • Developing innovator Form (Tosylate monohydrate form 1), a gram sample can be offered.
  • Particle size distribution (PSD) - We can offer customized particle sizes based on customer requirements.
  • Reliable KSM suppliers added to ensure timely deliveries and adherence to stringent specifications.
  • Planning adequate capacity to supply development quantity in a short lead time.

To learn more about our API offerings, please read the Tech sheet on Niraparib API by filling out the contact form below.

Explore other Whitepapers:

Know More

Download Now

Please fill the Contact form below in order to view the white paper

Email us: api@drreddys.com | +91 40 49002222

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.